Investor News


Result of AGM

MedaPhor Group plc announces that at its Annual General Meeting held earlier today all resolutions proposed were duly passed by shareholders.


ScanNav AI software featured on ITV

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces its artificial intelligence (“AI”) based real-time image analysis software, ScanNav™ has featured on the ITV ‘Wales This Week’ programme. ScanNav uses deep learning-based algorithms to automatically identify, grade and capture good ultrasound images to provide real-time guidance, assessment and audit of obstetric scanning. It is believed to be the first AI system to carry out an automated, real-time "peer review" of obstetric ultrasound images as the patient is scanned. The technology is currently being piloted at the Fetal Medicine Department of St George's University Hospitals NHS Trust [...]


Notice of annual general meeting

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that the Company's Annual General Meeting ("the AGM") will be held will be held at IP Group Offices, The Walbrook Building, 25 Walbrook, London, EC4N 8AF on 17 May 2018 at 10.30am. The Group's 2017 Annual Report which contains the formal notice of the AGM has today been posted on the Group's website, www.medaphor.com. Hard copies of the Annual Report including the Notice and a form of proxy for use at the AGM have been posted to all shareholders. Medaphor is committed to reducing paper and improving [...]


Unaudited preliminary results

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces its preliminary results for the year ended 31 December 2017, a pivotal year where the Company expanded into the larger clinical ultrasound software market. Financial highlights Revenues increased 27% to £4.2m (2016: £3.3m North America sales double to £1.7m Rest of World sales up 44% to £1.8m, with 83% growth for sales into China Raised £5.4m net of costs by way of placing of shares Year-end cash at £4.3m (2016: £1.8m) Operational highlights Acquired Intelligent Ultrasound Limited bringing artificial intelligence expertise to the Group Won UK Government [...]


Notice of results

Investor results presentation MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces it will be reporting its final results for the year ended 31 December 2017 on Wednesday, 21 March 2018. Investor briefing Stuart Gall (CEO), Wilson Jennings (FD) and Nicholas Sleep (CTO) will be hosting a briefing for investors on Wednesday, 21 March from 3.30pm to 5pm at the offices of IP Group. There will be an opportunity to see live demonstrations of a number of MedaPhor’s products, including ScanTrainer, HeartWorks and the newly launched BodyWorks simulator platforms, as well as demonstrations of the new [...]


Opening of Hong Kong office

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that it has opened an office in Hong Kong to facilitate the Group’s established reseller network and growing customer base in the Asia-Pacific (APAC) region. The Group now has 18 active reseller partners in this region selling the ScanTrainer, HeartWorks and new BodyWorks Eve simulation portfolio into hospitals and university teaching schools. The new Hong Kong office will support and aim to expand reseller sales, marketing and customer relations across the APAC region and especially in the growing Chinese simulation market. The Company has appointed a local [...]


Launch of new point-of-care ultrasound simulator

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces the launch of its new BodyWorks Eve simulator platform, an ultra-realistic manikin-based simulator to train medical professionals practising Point-of-Care Ultrasound (PoCUS) across emergency medicine and critical care. First revealed at the International Meeting on Simulation in Healthcare (IMSH) in Los Angeles last month and now launched for general sale, the BodyWorks Eve is believed to be the first hi-fidelity female manikin-based simulator for emergency PoCUS training. BodyWorks Eve combines the normal and pathological hearts from MedaPhor’s HeartWorks simulator with the complete upper chest to pelvis real patient [...]


Pilot of ultrasound AI software for pregnancy screening

ScanNav real-time image analysis software to be piloted by St George's, London MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces the first pilot of its ScanNav real-time image analysis software at the Fetal Medicine Department of St George's University Hospitals NHS Trust, London, U.K. ScanNav is believed to be the first CE marked artificial intelligence (AI) system to carry out an automated, real-time "peer review" of obstetric ultrasound images as the patient is scanned. Monitoring performance by manually auditing images retrospectively is very time consuming, so ScanNav instead supports clinical staff by instantly confirming that [...]


Investor presentation

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that it will be presenting at the Shares and AJ Bell Spotlight Evening in London on Tuesday 13 February 2018. The Shares and AJ Bell Investor evening provides an opportunity for Directors to make a presentation and talk about their company business plans for 2018 direct to existing and potential investors. The event will commence at 6pm at Novotel Tower Bridge, London, EC3N 2NR. At the event CEO Stuart Gall will deliver a presentation detailing the Company’s strategy following the recent acquisition of Intelligent Ultrasound Limited, along [...]


Innovate UK grant award confirmed

MedaPhor initiates development of new Augmented Reality NeedleGuideTM system MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that it has today initiated the first phase of development of NeedleGuide, its new augmented reality imaging device, following confirmation of the Innovate award funding, conditionally announced in November last year. The grant of £466,000 was awarded as part of Innovate UK’s Digital Health Technology Catalyst competition and will part-fund the development of MedaPhor’s NeedleGuide product, which the Company believes has the potential to revolutionise interventional ultrasound-guided needling. Doctors use interventional needling in a variety of medical procedures [...]

;